Immunai Enters Collaboration With Teva Focused On Immunology ...

Key focus areas will include drug mechanism of action, dose selection, and biomarker analyses. Immunai Enters Collaboration with Teva focused on ...

Immunai and Teva launch multi-tear AI collaboration for smarter ...

The partnership will utilize Immunai's cutting-edge immune system mapping tools to enhance precision in immunology and oncology trials.

Immunai and Teva Collaborate to Advance Clinical Trials in ...

Immunai, an AI-driven biotech company focused on mapping the human immune system, has partnered with Teva Pharmaceuticals in a multi-year ...

Immunai and Teva partner to innovate new cancer, immunology ...

Immunai Inc., an artificial intelligence biotechnology company, announced on Thursday a multi-year collaboration in immunology and ...

Drug Discovery and Development | Contract Pharma

Drug Discovery and Development · Immunai Enters Collaboration with Teva focused on Immunology & Immuno-Oncology · Avantor Opens Flagship Bridgewater Innovation ...

Immunai and Teva Partner to Develop Innovative Therapies

Recently, the pharmaceutical company announced a collaboration with the biotechnology company Immunai Inc. to advance immunology and immuno ...

Immunai - Startup Nation Finder

Immunai is developing a proprietary data set of multi-omic, immune-centric peripheral tissue analyses.

Treating the untreatable: what are biologics? - Teva Pharmaceuticals

Working across immunology and neuroscience, Teva is focused on identifying highly targeted antibodies to fight disease. With recent launches ...

biotech - Parenteral Drug Association

Key focus areas will include drug mechanism of action, dose selection, and biomarker analyses. Immunai Inc., an artificial intelligence (AI)...

Immunai - CTech

Immunai and Teva launch multi-tear AI collaboration for smarter drug development · Immunai signs $18M collaboration with AstraZeneca to make cancer drug trials ...

Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk ...

Teva and Alvotech entered into a strategic partnership for the exclusive commercialization of five of Alvotech's biosimilar product ...

Press Release: Sanofi and Teva announce exclusive collaboration ...

We are honored to partner with Sanofi to bring their proven capabilities, leadership, and success in the immunology and gastroenterology space ...

Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A ...

... immunology. This partnership could potentially lead to a ... On October 3, 2023, Teva and Sanofi entered into an exclusive collaboration ...

Sanofi, Teva Ink Potential $1.5B Deal Aimed at Blockbuster IBD Drug

In June 2023, Merck finalized a $10.8 billion buy of Prometheus Biosciences to get its hands on five immune-mediated disease assets. The lead ...

Immunai - Decoding immunity

We are a multidisciplinary team of immunologists, engineers, drug developers, computer scientists, and entrepreneurs singularly focused on bringing ...

Teva and Alvotech Further Strengthen Their Relationship, Reach ...

Per the US strategic partnership agreement, the adalimumab high-concentration interchangeable biosimilar will be distributed under the Quallent ...

Israeli AI startup forges $18m partnership with AstraZeneca for ...

As part of the collaboration, drugmaker will use Immunai's AI model of the immune system and machine learning for clinical decision-making ...

TEVA PHARMACEUTICAL INDUSTRIES LIMITED - SEC.gov

hearing focused on pricing of branded ... On October 3, 2023, Teva entered into an exclusive collaboration with Sanofi to co-develop and.

Alvotech and Teva Announce U.S. FDA Approval of Additional ...

In August 2020, Alvotech and Teva entered into a strategic partnership for the exclusive commercialization of five of Alvotech's biosimilar ...

Teva Hooks Immunology Powerhouse Sanofi In $1.5 Billion Deal

... Teva Pharmaceuticals partnership with Sanofi on a new immunology drug. "It can ... focused on developing therapies that modulate novel ...